Oppenheimer Forecasts Strong Price Appreciation for Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare (NASDAQ:ADUS) had its target price boosted by research analysts at Oppenheimer from $145.00 to $150.00 in a research report issued on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s target price indicates a potential upside of 16.88% from the company’s current price.

ADUS has been the subject of a number of other research reports. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. Royal Bank of Canada restated an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. KeyCorp started coverage on Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target for the company. Macquarie reaffirmed an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, StockNews.com upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Friday. One analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $134.22.

Addus HomeCare Price Performance

Shares of ADUS traded up $1.23 on Friday, reaching $128.34. The company’s stock had a trading volume of 28,719 shares, compared to its average volume of 131,686. The stock’s 50 day simple moving average is $125.88 and its two-hundred day simple moving average is $126.88. Addus HomeCare has a 12-month low of $85.94 and a 12-month high of $136.72. The stock has a market capitalization of $2.33 billion, a P/E ratio of 29.39, a PEG ratio of 1.73 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. During the same quarter in the previous year, the company posted $1.03 EPS. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. Analysts expect that Addus HomeCare will post 4.58 earnings per share for the current year.

Insider Activity

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 39,750 shares of company stock valued at $4,930,750. Insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors have recently modified their holdings of the business. Quarry LP acquired a new position in Addus HomeCare in the 3rd quarter worth $28,000. Farther Finance Advisors LLC boosted its position in Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after buying an additional 366 shares in the last quarter. KBC Group NV increased its position in Addus HomeCare by 49.1% in the 4th quarter. KBC Group NV now owns 814 shares of the company’s stock valued at $102,000 after acquiring an additional 268 shares during the period. GAMMA Investing LLC lifted its stake in shares of Addus HomeCare by 25.7% in the third quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock worth $124,000 after acquiring an additional 191 shares during the period. Finally, Assetmark Inc. lifted its stake in Addus HomeCare by 11.5% in the third quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock valued at $156,000 after buying an additional 121 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.